EZH2 co-opts gain-of-function p53 mutants to promote cancer growth and metastasis
Y. Zhao, L. Ding, D. Wang, Z. Ye, Y. Pan, L. Ma, R. Coleman, I. Coleman, R. J. Karnes, J. Zhang, P. S. Nelson, L. Wang, R. Zhu, H. Huang
This study identifies EZH2 as a p53 mRNA-binding protein that enhances translation of gain-of-function p53 mutants, promoting cancer growth and metastasis, and shows that inhibiting EZH2 causes synthetic lethality in these cells.
bioRxiv · Apr 10, 2018Cancer Biology